Notice Number: NOT-HL-17-557
Key Dates
Release Date: November 3, 2017
RFA-HL-18-025
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform potential applicants that an additional due date has been added to RFA-HL-18-025 "Limited Competition: Small Grant Program for NHLBI K01/K08/K23 Recipients (R03 Clinical Trial Optional)". This additional application due date is in response to the early expiration of RFA-HL-16-020. The Key Dates section of RFA-HL-18-025 has been revised as presented below, with additions emphasized in bold.
Part 1. Key Dates
Currently reads:
Posted Date |
October 6, 2017 |
Open Date (Earliest Submission Date) |
January 15, 2018 |
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
February 15, 2018; June 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review |
June 2018, October 2018 |
Advisory Council Review |
August 2018, October 2019 |
Earliest Start Date |
September 2018, April 2019 |
Expiration Date |
September 8, 2018 |
Modified to read:
Posted Date |
October 6, 2017 |
Open Date (Earliest Submission Date) |
January 15, 2018 |
Letter of Intent Due Date(s) |
30 days prior to the application due date |
Application Due Date(s) |
February 15, 2018; June 14, 2018; October 17, 2018 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review |
June 2018, October 2018, March 2019 |
Advisory Council Review |
August 2018, January 2019, May 2019 |
Earliest Start Date |
September 2018, April 2019, July 2019 |
Expiration Date |
January 8, 2019 |
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Scientific/Research Contact(s)
Lisbeth Welniak, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8297
Email: welniakla@mail.nih.gov
Peer Review Contact(s)
Director, Office of Scientific Review
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0270
Email: nhlbichiefreviewbranch@nhlbi.nih.gov
Financial/Grants Management Contact(s)
Mykle Lyons
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8043
Email: mykle.lyons@nih.gov
and Human Services (HHS)
